Target Price | $32.80 |
Price | $14.56 |
Potential |
125.28%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Arcus Biosciences 2025 .
The average Arcus Biosciences target price is $32.80.
This is
125.28%
register free of charge
$46.00
215.93%
register free of charge
$20.00
37.36%
register free of charge
|
|
A rating was issued by 11 analysts: 8 Analysts recommend Arcus Biosciences to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arcus Biosciences stock has an average upside potential 2025 of
125.28%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 117.00 | 260.92 |
4.46% | 123.01% | |
EBITDA Margin | -276.92% | -116.85% |
16.60% | 57.80% | |
Net Margin | -324.55% | -116.64% |
7.08% | 64.06% |
9 Analysts have issued a sales forecast Arcus Biosciences 2024 . The average Arcus Biosciences sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Arcus Biosciences EBITDA forecast 2024. The average Arcus Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Arcus Biosciences Analysts have issued a net profit forecast 2024. The average Arcus Biosciences net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.15 | -3.33 |
11.86% | 19.76% | |
P/E | negative | |
EV/Sales | 1.16 |
10 Analysts have issued a Arcus Biosciences forecast for earnings per share. The average Arcus Biosciences <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Arcus Biosciences stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Arcus Biosciences...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.